Ilan Ganot

Ilan Ganot is a seasoned professional in the biotechnology and finance sectors, currently serving as Chief Executive Officer of Alesta Therapeutics since February 2024. Ganot holds board member positions at Minovia Therapeutics and Solid Biosciences, where Ilan also serves as Founder, President, and CEO, focusing on drug development for Duchenne Muscular Dystrophy. Prior experience includes roles as a Hedge Funds Specialist at JPMorgan Chase and positions in equities at Nomura and Lehman Brothers, where long/short equity recommendations were provided for hedge fund clients. Early career experience includes serving as a corporate lawyer at Haim Zadok & Co., Advocates, specializing in corporate law, private equity, and M&A. Ganot earned an MBA in Finance from London Business School and holds dual bachelor's degrees in Business Administration and Law from Reichman University.